CASE STUDIES OF PUBLIC HEALTH RESEARCH THAT HAVE ALTERED PUBLIC POLICY THE NEW HAVEN SEP EVALUATION.

Slides:



Advertisements
Similar presentations
Syringe Access Programs & Law Enforcement: Building Alliances New York State Current April 2012.
Advertisements

Organizing Drug Users for Community & Social Change.
New Haven Needle Exchange Program Was it effective in reducing HIV transmission? Was it cost-effective?
Operations Research2  The problem  With the advent of HIV and AIDS in the early 1990s, the City of New Haven instituted a needle exchange program as.
HIV in the United Kingdom: 2013 HIV and AIDS Reporting Section Centre for Infectious Disease Surveillance and Control (CIDSC) Public Health England London,
Neighborhood Variations in Syringe Access, Use, and Discard Robert Heimer, Kaveh Khoshnood, Wei Teng, David Buchanan, Tom Stopka, & Merrill Singer Acknowledgement:
Hepatitis C Action Plan Prevention Working Group Findings and recommendations Norah Palmateer Health Protection Scotland Greater Glasgow & Clyde MCN June.
Ecological Model for HIV Risk in MSM Stage of Epidemic Individual Community Public Policy Network Level of Risks Source: Baral and Beyrer, 2006.
Thailand’s HIV and AIDS STRATEGY
GAP Report 2014 Prisoners People left behind: Prisoners Link with the pdf, Prisoners.
WHAT IS THE RELATIONSHIP BETWEEN PRISONS AND RATES OF HIV/AIDS?
HIV/AIDS epidemiology and prevention policy in Finland Mika Salminen Kansanterveyslaitos – KTL National Public Health Institute.
HIV and Hepatitis C in non- MSM Rural Communities: Issues and Interventions Shari Wells-Weiss, CASAC Director of Prevention Services Southern Tier AIDS.
HIV, Drugs & Prisons Photo by Mr. Alessandro Scotti, UNODC Good Will Ambassador Gino Vumbaca.
PAF101 PAF 101 Skill Set Number 10: Problem Solving 1.Identify the Problem 2.Develop Solutions 3.Launch Solutions Module 5, Lecture 8.
Slide 5.1 Topic 5. Supporting programs aimed at reducing the spread of HIV among and from IDU Needle and Syringe Programs Opioid Substitution Treatment.
Enhancing HIV/AIDS Surveillance in California California Department of Public Health Office of AIDS Guide for Health Care Providers.
Syringes in Paradise Over 20 Years of Syringe Exchange in Hawai ʿ i Heather Lusk CHOW Project
California Department of Public Health Office of AIDS Access to Sterile Syringes: Changes to California Law Alessandra Ross, MPH InjectionUse Specialist.
Overview of Syringe Exchange Programs New York City Police Academy November 24, 2004.
Afghanistan’s Present IDUs-HIV/AIDS Situation and future action plan Dr.Saifur-Rehman NACP Director April,11,2007 Islamic Republic of Afghanistan Ministry.
HIV/AIDS Chapter 21 Human Immunodeficiency Virus (HIV) Acquired immune Deficiency Syndrome (AIDS) (Pg 496)
Use of Network Analysis During a Tuberculosis Investigation Outbreak Investigation Section Surveillance and Epidemiology Branch Division of Tuberculosis.
Concepts in Infectious Disease Epidemiology: Models & Prediction David Vlahov, Ph. D.
Centers for Disease Control and Prevention CDC Half-Year of Diagnosis** Number of Cases **Adjusted for reporting delay AIDS Cases in Racial/Ethnic Minorities*
Overview of Harm Reduction and Sterile Syringe Access Anna Benyo Syringe Access Policy Coordinator Harm Reduction Coalition New Jersey Syringe Access Informational.
Working with SEPs: How do we expand Hepatitis Services ? Narelle Ellendon, RN HCV Director Harm Reduction Coalition, NYC
HIV/AIDS prevention and care among injecting drug users and in prison settings in Estonia, Latvia and Lithuania Signe ROTBERGA UNODC, Baltic States 5 November.
HIV, drugs and the legal environment Steffanie A. Strathdee (University of California San Diego, La Jolla, CA, USA), Leo Beletsky (Northeastern University.
The Governance of Care: Mapping Local Influences on IDU Health Interventions in a Polish City Sobeyko J (1)(8), Leszczyszyn-Pynka M (1)(2), Duklas T (7),
Hepatitis C, Drug Use and Stigma Liz Allen. What it is Hepatitis C? Hepatitis C is a blood-borne virus Can cause serious damage to the liver First indentified.
U.S. Civilian Research & Development Foundation Peace and prosperity through science collaboration Estonia: overlaping epidemics of IDU and HIV Anneli.
Public Health in Tropics :Further understanding in infectious disease epidemiology Taro Yamamoto Department of International Health Institute of Tropical.
Reducing HIV and HCV Transmission among Injecting Drug Users in New York.
November 2012 Prepared for the Contra Costa Board of Supervisors by Contra Costa Health Department Needle Exchange Update.
2008 Minnesota HIV/AIDS Surveillance Report - Key Trends Lorraine Teel- Executive Director.
Lifting the Federal Ban on the funding of syringe exchange: An advocacy campaign Allan Clear XVIII International AIDS Conference.
A Global Overview of Safe Injection Facilities: Key Policies and Practices Andrew Reynolds The DOPE Project Alliance for Saving Lives.
Quarterly HIV/AIDS Analysis for Michigan January 1, 2008 Michigan Department of Community Health HIV/STD/Viral Hepatitis and TB Epidemiology Section Division.
 Policy initiatives Surveillance data use Leveraging SAMHSA HIV set- aside funds Healthcare reform planning  Condom distribution & syringe supply bank.
SSuN: MSM prevalence monitoring and HIV Testing in STD Clinics Kristen Mahle & Lori Newman SSuN Call #3 Oct 30, 2008.
Washington D.C., USA, July 2012www.aids2012.org Alternatives to NSEPs: community-based initiatives Providing access to syringes in the politically.
HCV in injecting drug users: developing indicators of prevalence and responses VHPB WHO Consultation Meeting Geneva, 13 May 2002 Lucas Wiessing European.
National roll-out of database for HIV prevention programmes among civil society organizations in Ukraine Olga Varetska ICF “International HIV/AIDS Alliance.
Paradoxes and Problems in Preventing HIV Infection among Injecting Drug Users and Their Sexual Partners in Eastern Europe and Asia Don C. Des Jarlais,
HIV & AIDS In Homosexuals By: Kristen Hopkins, Lizbeth Londono, & Marcela Morado.
Kow-Tong Chen, M.D., Ph.D., Hsiao-Ling Chang, Ph.D., Chu-Tzu Chen, M.P.H., and Ying-An Chen, M.P.H. Volume 23, Number 3, 2009 AIDS PATIENT CARE and STDs.
Treatment and scale up access TV, ART OST treatment for people who use drug sin SEA Ekta.
Country gallery Maldives. Basic socio-demographic indicators, Total population (thousands)306 Annual population growth rate2.4 Population aged.
School of Public Health and Community Medicine How policies and repressive law- enforcement fuel the HIV epidemic among people who inject drugs Professor.
Pharmacists and Social Health
Effects of Pharmacy Syringe Access Among Young Heroin Injectors Results IDU needle sharing decreased after the enactment of the pharmacy access law in.
Jennifer R. Havens, PhD, MPH Associate Professor
IDUHA Hepatitis C Peer Navigation Program Brooklyn Hep C Task Force Meeting Brooklyn Borough Hall March 9, 2016 Viral Hepatitis Surveillance, Prevention.
From evidence to commitment to action: implementing HIV prevention measures in prisons in Ukraine XVI International AIDS Conference Toronto, 15 August.
Non-Medical Staff Knowledge, Beliefs and Practices about HIV and Hepatitis for Injection Drug Users Rowe, KA 1, Tesoriero, JM 1, Heavner, KK 1, Rothman,
HUMAN RIGHTS ISSUES RELATED TO THE EVALUATION OF AN ILLEGAL NEEDLE EXCHANGE PROGRAM Debra Harris, Ph.D., California State University, Fresno.
PREVENTION OF INFECTIOUS DISEASES IN PRISONS Recent Experience from Portugal Henrique Barros Ministério da Saúde.
Jana Feldmane Ministry of Health of Latvia Public Health Department Health care overview in prisons.
Name(s) Here Job Title(s) Here.
Syringe Exchange Programs in NC
Developing Measures of Pathways That May Link Large-scale Social Structural Factors with HIV Epidemiology Enrique R. Pouget, Milagros Sandoval, Yolanda.
Needle Exchange Update
Syringe Exchange Programs in NC
Utilization of New York State Syringe Exchange Programs:
PAF 101 Module 5, Lecture 8 Skill Set Number 10: Problem Solving Identify the Problem Develop Solutions Launch Solutions.
PAF 101 Module 5, Lecture 8 Skill Set Number 10: Problem Solving Identify the Problem Develop Solutions Launch Solutions.
There are over 200 syringe access service programs (SSP) in the United States. These programs provide sterile syringes to people who inject drugs and.
Addressing Privacy and Security In Nebraska
Human Dignity and Harm Reduction
Presentation transcript:

CASE STUDIES OF PUBLIC HEALTH RESEARCH THAT HAVE ALTERED PUBLIC POLICY THE NEW HAVEN SEP EVALUATION

HIV-1 TRANSMISSION AMONG IDUs l Behavioral risk factors include:  Syringe sharing  Shooting gallery attendance  Sharing drugs l Behavioral risks are driven by societal factors.  Fear of arrest  Aversion to withdrawal  Scarcity of syringes

HISTORY OF SYRINGE EXCHANGE l Syringe exchange began in Holland in response to a hepatitis outbreak. l It is impossible to say when syringe exchange first began in the US. l The first openly operating initiative began in Tacoma in 1988.

WHY A SYRINGE EXCHANGE PROGRAM IN NEW HAVEN l In contrast to national data, 70% of AIDS cases in New Haven could be attributed to injection drug use.

ESTABLISHING THE SEP IN NEW HAVEN, CONNECTICUT l The city established a task force to seek solutions to the AIDS epidemic that lobbied for three years ( ) to change the laws to start a SEP.  By statute, customers could exchange no more than five syringes in a strict one-for-one fashion.  A evaluation report had to be produced and issued within one year. l The SEP, operated by the city health department, opened on November 13, 1990.

EVALUATING THE NEW HAVEN SEP l Minimize reliance on self-reported data. l Investigate the link between the operations of the program and its effects. l Maintain the anonymity of the participants. l Provide a timely analysis that measures the program's effectiveness.

SYRINGE TRACKING AND TESTING l All outgoing syringes coded and exchanges recorded. l All returned syringes recorded in second database. l Nearly 50,000 syringes exchanged in first three years of the SEP. l Approximately one-tenth of all returned syringes tested for presence of blood from HIV-1 infected individual.

SEP FOUND TO PREVENT NEW HIV INFECTIONS l The testing data were used to generate two models to estimate the HIV incidence rate. l The first, an ecological model, assumed that in the absence of exchange previously used syringes will be used at random. l The second, a changepoint model, assumed that sequential testing of syringes returned by individuals yields reliable longitudinal data.

MODEL 1: TRANSMISSION OF SYRINGE-BORNE INFECTIONS  x  x   Incidence is equal to the rate at which an uninfected injector uses a potentially infectious syringe without first disinfecting it times the rate which the exposure results in infection.

THE TWO MODELS INCIDENCE ESTIMATES BASED ON THE TWO MODELS l Using model 2, the most likely incidence rate was estimated at 1.6% per year, less than half the estimate from model 1.

EFFECT OF SEP EVALUATION ON POLICY IN CONNECTICUT l In 1992, the state government reviewed the findings and  Removed the “demonstration” status.  Increased syringe exchange limit from 5 to 10 syringes per visit.  Added five new SEPs in other cities.  Allowed syringes to be purchased from pharmacies. l In 1999, the state again increased the limit on syringes from 10 to 30 per visit.

EFFECT OF SEP EVALUATION ON POLICY IN OTHER STATES l Neighboring states of New York and Massachusetts legalize SEPs. l California legislation cites New Haven studies. l Only three states continue to keep SEPs illegal. HIV Prevalence among IDUs in New York City following SEP Legalization

EFFECT OF SEP EVALUATION ON FEDERAL GOVERNMENT POLICY l U. S. government reports repeatedly certify that New Haven evaluation clearly demonstrated that SEPs can reduce HIV transmission among IDUs. l Nevertheless, Congress refuses to change law that makes federal funding of SEPs illegal. l U. S. continues to seek international disapproval of syringe exchange.